Search results
Decoding Biogen Inc (BIIB): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 6 days agoBiogen Inc's robust product portfolio and pipeline offer a competitive edge in the neurology and immunology sectors. Despite a slight revenue dip, Biogen
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 5 hours ago“As we reflect on the past year and set our sights on the path ahead, I am truly inspired by the progress we have made to advance Biogen’s enduring legacy of pioneering innovative ...
FY2024 Earnings Forecast for Biogen Inc. (NASDAQ:BIIB) Issued By Cantor Fitzgerald
ETF DAILY NEWS· 3 days agoBiogen Inc. (NASDAQ:BIIB – Free Report) – Research analysts at Cantor Fitzgerald lifted their FY2024 earnings per share (EPS) estimates for Biogen in a ...
Biogen (BIIB)'s Market Evaluation: A Fair Valuation Analysis
Guru Focus· 3 days agoBiogen Inc (BIIB, Financial) has recently experienced a daily gain of 4.43%, but this contrasts with a three-month loss of -12.67%. This article aims to delve into the valuation ...
Biogen Inc. (NASDAQ:BIIB) Just Released Its First-Quarter Earnings: Here's What Analysts Think
Simply Wall St. via Yahoo Finance· 5 days agoIt's been a good week for Biogen Inc. (NASDAQ:BIIB) shareholders, because the company has just...
Biogen First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Simply Wall St. via Yahoo Finance· 4 days agoBiogen (NASDAQ:BIIB) First Quarter 2024 Results Key Financial Results Revenue: US$2.29b (down 7.0%...
Biogen Inc. (NASDAQ:BIIB) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 days agoBiogen Inc. (NASDAQ:BIIB) Q1 2024 Earnings Call Transcript April 24, 2024 Biogen Inc. misses on...
Needham & Company LLC Reiterates Buy Rating for Biogen (NASDAQ:BIIB)
ETF DAILY NEWS· 7 days agoBiogen (NASDAQ:BIIB – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at Needham & Company LLC in a research note issued to investors on Wednesday ...
The Analyst Landscape: 27 Takes On Biogen - Biogen (NASDAQ:BIIB)
Benzinga· 3 days agoLoading... Loading... In the preceding three months, 27 analysts have released ratings for Biogen BIIB , presenting a wide array of perspectives from bullish to bearish. The ...
William Blair Weighs in on Biogen Inc.’s Q3 2024 Earnings (NASDAQ:BIIB)
ETF DAILY NEWS· 4 days agoBiogen Inc. (NASDAQ:BIIB – Free Report) – Investment analysts at William Blair upped their Q3 2024 earnings per share (EPS) estimates for shares of Biogen